The end of phase 1 I would think should be about complete. It's a 6 week program and with most subjects starting the trial immediately after the 8-k was announced and just a few a bit later. I have around a December completion figured and an immediate phase 2 ready to start. Proving efficacy in phase 2 will be a major catalyst for the company and stock holders.